ZMB Site - Medical Faculty / University Hospital Essen
ZMB Research
Sites
Medical Faculty / University Hospital Essen

Prof. Dr. Dr.Jürgen Becker
Group: Translational Skin Cancer Research
ZMB Research Program: Oncology
More
Prof. Dr.Jan Buer
Director of: Institute of Medical Microbiology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Elke Cario
Group: Experimental Gastroenterology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Ulf Dittmer
Director of: Institute of Virology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Nicole Dünker
Group: Neuroanatomy
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Joachim Fandrey
Director of: Institute of Physiology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Jun.-Prof. Dr.Katja Ferenz
Group: Institute of Physiology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Katharina Fleischhauer
Director of: Institute for Experimental Cellular Therapy
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Stefanie Flohé
Group: Immunology Sepsis/Trauma
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Dagmar Führer-Sakel
Director of: Clinic for Endocrinology, Diabetology and Metabolism
ZMB Research Program: Oncology
More
Prof. Dr.Bernd Giebel
Group: Giebel
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Erich Gulbins
Director of: Department of Molecular Biology
ZMB Research Program: Oncology
More
Prof. Dr.Matthias Gunzer
Director of: Institute of Experimental Immunology & Imaging
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Wiebke Hansen
Group: Molecular Infection Immunology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
PD Dr.Ulrike Hendgen-Cotta
Manager of: Cardio Science Labs
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Dirk M. Hermann
Group: Vascular Neurology, Dementia and Age Research
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Heike Heuer
Group: Molecular Thyroidology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Anke Hinney
Group: LVR Clinic for Psychiatry Essen
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Peter Horn
Director of: Institute for Transfusion Medicine
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Carsten Kirschning
Group: Regulation of Pathogen-specific Immunity
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Diana Klein
Group: Vascular Remodeling & Normal Tissue Protection
ZMB Research Program: Oncology
More
Prof. Dr.Christoph Kleinschnitz
Director of: Clinic for Neurology
ZMB Research Program: Molecular and Chemical Cell Biology
More
PD Dr.Adalbert Krawczyk
Group: Clinic for Infectious Diseases
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Ralf Küppers
Director of: Institute of Cell Biology (Tumor Research)
ZMB Research Program: Oncology
More
Prof. Dr.Karl Sebastian Lang
Director of: Institute of Immunology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Dietmar Lohmann
Group: Ophthalmic Oncology and Genetics
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Katharina Lückerath
Group: Preclinical Theranostics in Nuclear Medicine
ZMB Research Program: Oncology
More
Prof. Dr.Cläre von Neubeck
Group: Translational Particle Therapy
ZMB Research Program: Oncology
More
Prof. Dr.Jochen Niemeyer
Group: Supramolecular Organocatalysis and Chemosensing
ZMB Research Program: Molecular and Chemical Cell Biology
More
Dr.Samuel Peña-Llopis
Junior Group: Translational Genomics in Solid Tumors
ZMB Research Program: Oncology
More
Prof. Dr.Tienush Rassaf
Director of: Clinic for Cardiology and Vascular Medicine
ZMB Research Program: Oncology
More
Prof. Dr.Christian Reinhardt
Director of: Clinic for Hematology and Stem Cell Transplantation
ZMB Research Program: Oncology
More
Prof. Dr.Alexander Roesch
Group: Tumor Heterogeneity & Plasticity
ZMB Research Program: Oncology
More
Prof. Dr.Kurt Werner Schmid
Director of: Institute of Neuropathology
ZMB Research Program: Oncology
More
Prof. Dr.Martin Schuler
Director of: Department of Medical Oncology
ZMB Research Program: Oncology
More
Prof. Dr.Winfried Siffert
Director of: Institute of Pharmacogenetics
ZMB Research Program: Molecular and Chemical Cell Biology
More
PD Dr.Bernhard B. Singer
Group: Institute of Anatomy
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr. Dr.Jens Siveke
Group: Bridge Institute for Experimental Tumor Therapy
ZMB Research Program: Oncology
More
PD Dr.Kathrin Sutter
TRR60 Junior Research Group: Interferone-alpha Subtypes
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Dr.Silvia Vega-Rubín-de-Celis
Junior Research Group: Autophagy in Cancer
ZMB Research Program: Oncology
MoreSelected Publications
-
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients with Resectable or Borderline Resectable Disease (COMM-PACT-RB) : A Systematic Review and Delphi Consensus StatementIn: JAMA Oncology (2022) in press
ISSN: 2374-2445; 2374-2437Online Full Text: dx.doi.org/ -
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations : Results from a Multi-institutional European Retrospective StudyIn: Clinical Cancer Research Vol. 28 (2022) Nr. 8, pp. 1672 - 1679
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ (Open Access) -
ACKR3 regulates platelet activation and ischemia-reperfusion tissue injuryIn: Nature Communications Vol. 13 (2022) Nr. 1,
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationIn: Clinical Cancer Research Vol. 28 (2022) Nr. 5, pp. 1004 - 1012
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ -
Persister state-directed transitioning and vulnerability in melanomaIn: Nature Communications Vol. 13 (2022) Nr. 1,
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Cellular plasticity upon proton irradiation determines tumor cell radiosensitivityIn: Cell Reports Vol. 38 (2022) Nr. 8,
ISSN: 2211-1247Online Full Text: dx.doi.org/ (Open Access) -
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor MicroenvironmentIn: Cancer Research Vol. 82 (2022) Nr. 2, pp. 264 - 277
ISSN: 1538-7445; 0099-7374Online Full Text: dx.doi.org/ -
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716) : a randomised, double-blind, phase 3 trialIn: Lancet Vol. 399 (2022) Nr. 10336, pp. 1718 - 1729
ISSN: 1474-547X; 0140-6736; 0023-7507; 0099-5355Online Full Text: dx.doi.org/ -
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignanciesIn: European Heart Journal (2022) in press
ISSN: 0195-668X; 1522-9645Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyIn: European Heart Journal Vol. 43 (2022) Nr. 4, pp. 316 - 329
ISSN: 0195-668X; 1522-9645Online Full Text: dx.doi.org/ -
Preneoplastic somatic mutations including MYD88L²⁶⁵P in lymphoplasmacytic lymphomaIn: Science Advances Vol. 8 (2022) Nr. 3,
ISSN: 2375-2548Online Full Text: dx.doi.org/ (Open Access) -
DJ-1 depletion prevents immunoaging in T-cell compartmentsIn: EMBO Reports Vol. 23 (2022) Nr. 3,
ISSN: 1469-3178; 1469-221XOnline Full Text: dx.doi.org/ (Open Access) -
Imaging innate immunity*In: Immunological Reviews Vol. 306 (2022) Nr. 1, pp. 293 - 303
ISSN: 0105-2896; 1600-065XOnline Full Text: dx.doi.org/ (Open Access) -
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expressionIn: Nature Communications Vol. 13 (2022) Nr. 1,
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Stroke induces disease-specific myeloid cells in the brain parenchyma and piaIn: Nature Communications Vol. 13 (2022) Nr. 1,
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Gastrointestinal stromal tumours : ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-upIn: Annals of Oncology Vol. 33 (2022) Nr. 1, pp. 20 - 33
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma : Interim analysis of the GMMG-CONCEPT trialIn: Leukemia Vol. 36 (2022) Nr. 3, pp. 885 - 888
ISSN: 1476-5551; 0887-6924Online Full Text: dx.doi.org/ (Open Access) -
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced MelanomaIn: The New England Journal of Medicine Vol. 386 (2022) Nr. 1, pp. 24 - 34
ISSN: 1533-4406; 0028-4793Online Full Text: dx.doi.org/ -
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute LeukemiaIn: Clinical Cancer Research Vol. 28 (2022) Nr. 5, pp. 870 - 881
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ (Open Access) -
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaIn: Blood Vol. 139 (2022) Nr. 4, pp. 538 - 553
ISSN: 1528-0020; 0006-4971Online Full Text: dx.doi.org/ -
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomasIn: Blood Vol. 137 (2021) Nr. 20, pp. 2785 - 2799
ISSN: 1528-0020; 0006-4971Online Full Text: dx.doi.org/ -
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesIn: Cancer Discovery Vol. 2 (2021) Nr. 1, pp. 70 - 91
ISSN: 2159-8290; 2159-8274Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialIn: The Lancet Oncology Vol. 22 (2021) Nr. 5, pp. 655 - 664
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ -
Cellular model system to dissect the isoform-selectivity of Akt inhibitorsIn: Nature Communications Vol. 12 (2021) Nr. 1,
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargosIn: Advanced Drug Delivery Reviews Vol. 173 (2021) pp. 479 - 491
ISSN: 1872-8294; 0169-409XOnline Full Text: dx.doi.org/ (Open Access) -
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS StudyIn: Clinical Cancer Research Vol. 27 (2021) Nr. 23, pp. 6333 - 6342
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersIn: Cancer Discovery Vol. 11 (2021) Nr. 11, pp. 2780 - 2795
ISSN: 2159-8290; 2159-8274Online Full Text: dx.doi.org/ -
Diagnostic Accuracy of ⁶⁸Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging TrialIn: JAMA Oncology Vol. 7 (2021) Nr. 11, pp. 1635 - 1642
ISSN: 2374-2445; 2374-2437Online Full Text: dx.doi.org/ -
Multiple Hepatic and Pulmonary Tumors Combined with Bilateral Adrenal Masses in a Young Woman with von Hippel–Lindau DiseaseIn: Gastroenterology Vol. 161 (2021) Nr. 4, pp. e1 - e4
ISSN: 1528-0012; 0016-5085Online Full Text: dx.doi.org/ -
Coating of cochlear implant electrodes with bioactive DNA-loaded calcium phosphate nanoparticles for the local transfection of stimulatory proteinsIn: Biomaterials Vol. 276 (2021)
ISSN: 1878-5905; 0142-9612Online Full Text: dx.doi.org/ -
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerIn: The New England Journal of Medicine Vol. 385 (2021) pp. 1091 - 1103
ISSN: 1533-4406; 0028-4793Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
NK cells in hypoxic skin mediate a trade-off between wound healing and antibacterial defenceIn: Nature Communications Vol. 12 (2021) Nr. 1,
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trialIn: The Lancet Oncology Vol. 22 (2021) Nr. 5, pp. 643 - 654
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ -
Neutrophils self-limit swarming to contain bacterial growth in vivoIn: Science Vol. 372 (2021) Nr. 6548,
ISSN: 1095-9203; 0036-8075Online Full Text: dx.doi.org/ -
Nomograms to predict outcomes after ¹⁷⁷Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer : An international, multicentre, retrospective studyIn: The Lancet Oncology Vol. 22 (2021) Nr. 8, pp. 1115 - 1125
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ (Open Access) -
PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected miceIn: EMBO Reports (2021)
ISSN: 1469-3178; 1469-221XOnline Full Text: dx.doi.org/ (Open Access) -
Protein Signatures of NK Cell–Mediated Melanoma Killing Predict Response to ImmunotherapiesIn: Cancer Research Vol. 81 (2021) Nr. 21, pp. 5540 - 5554
ISSN: 0099-7013; 1538-7445Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-IIn: Nature Communications Vol. 12 (2021) Nr. 1,
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
TRIP6 functions in brain ciliogenesisIn: Nature Communications Vol. 12 (2021) Nr. 1,
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defectsIn: Molecular Psychiatry Vol. 26 (2021) Nr. 12, pp. 7403 - 7416
ISSN: 1476-5578; 1359-4184Online Full Text: dx.doi.org/ (Open Access) -
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus TrametinibIn: Clinical Cancer Research Vol. 27 (2021) Nr. 16, pp. 4500 - 4510
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ (Open Access) -
The acid sphingomyelinase/ceramide system in COVID-19In: Molecular Psychiatry (2021) in press
ISSN: 1359-4184; 1476-5578Online Full Text: dx.doi.org/ (Open Access) -
Scaled preparation of extracellular vesicles from conditioned mediaIn: Advanced Drug Delivery Reviews Vol. 177 (2021)
ISSN: 0169-409X; 1872-8294Online Full Text: dx.doi.org/ -
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW) : a multi-cohort, open-label, registrational, phase 1/2 studyIn: The Lancet Diabetes and Endocrinology Vol. 9 (2021) Nr. 8, pp. 491 - 501
ISSN: 2213-8595; 2213-8587Online Full Text: dx.doi.org/ -
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1In: Blood Vol. 137 (2021) Nr. 5, pp. 646 - 660
ISSN: 1528-0020; 0006-4971Online Full Text: dx.doi.org/ -
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progressionIn: Nature Communications Vol. 12 (2021) Nr. 1,
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Sotorasib for Lung Cancers with KRAS p.G12C MutationIn: The New England Journal of Medicine (2021) in press
ISSN: 1533-4406; 0028-4793Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Agony of choice : How anesthetics affect the composition and function of extracellular vesiclesIn: Advanced Drug Delivery Reviews Vol. 175 (2021)
ISSN: 1872-8294; 0169-409XOnline Full Text: dx.doi.org/ -
Mapping the human genetic architecture of COVID-19In: Nature Vol. 600 (2021) pp. 472 - 477
ISSN: 0028-0836; 1476-4687Online Full Text: dx.doi.org/ (Open Access) -
Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality : Results from 49,089 COVID-19 inpatientsIn: Molecular Psychiatry (2021) in press
ISSN: 1359-4184; 1476-5578Online Full Text: dx.doi.org/ (Open Access) -
Bacterial protein domains with a novel Ig-like fold target human CEACAM receptorsIn: The EMBO Journal Vol. 40 (2021) Nr. 7, pp. e106103
ISSN: 1460-2075; 0261-4189Online Full Text: dx.doi.org/ (Open Access) -
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumoursIn: Annals of Oncology Vol. 32 (2021) Nr. 11, pp. 1332 - 1347
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasisIn: Cell Reports Vol. 37 (2021) Nr. 8,
ISSN: 2211-1247Online Full Text: dx.doi.org/ (Open Access) -
Metabolic requirements of NK cells during the acute response against retroviral infectionIn: Nature Communications Vol. 12 (2021) Nr. 1,
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
New players in the regulation of DNA-PK activity : Survivin joins the crowdIn: Cancer Research Vol. 81 (2021) Nr. 9, pp. 2270 - 2271
ISSN: 1538-7445; 0008-5472Online Full Text: dx.doi.org/ (Open Access) -
Nuclear medicine theranostics comes of ageIn: The Lancet Oncology Vol. 22 (2021) Nr. 11, pp. 1497 - 1498
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ -
Nuclear receptor coactivator NCOA3 regulates UV radiation⇓induced DNA damage and melanoma susceptibilityIn: Cancer Research Vol. 81 (2021) Nr. 11, pp. 2956 - 2969
ISSN: 1538-7445; 0008-5472Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Phase I assessment of safety and therapeutic activity of BAY1436032 in patients with IDH1-mutant solid tumorsIn: Clinical Cancer Research Vol. 27 (2021) Nr. 10, pp. 2723 - 2733
ISSN: 1078-0432; 1557-3265Online Full Text: dx.doi.org/ (Open Access) -
Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomasIn: Leukemia Vol. 35 (2021) pp. 2002 - 2016
ISSN: 0887-6924; 1476-5551Online Full Text: dx.doi.org/ (Open Access) -
PI3KC2β inactivation stabilizes VE‐cadherin junctions and preserves vascular integrityIn: EMBO Reports (2021) pp. e51299
ISSN: 1469-3178; 1469-221XOnline Full Text: dx.doi.org/ Online Full Text (Open Access) -
Antibody-guided in vivo imaging of Aspergillus fumigatus lung infections during antifungal azole treatmentIn: Nature Communications Vol. 12 (2021) Nr. 1, pp. 1707
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Reply to E. HindiéIn: Journal of Clinical Oncology Vol. 39 (2021) Nr. 8, pp. 944 - 946
ISSN: 1527-7755; 0732-183XOnline Full Text: dx.doi.org/ -
PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman PrimatesIn: Clinical Cancer Research Vol. 27 (2021) Nr. 7, pp. 2050 - 2060
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/; Online Full Text: dx.doi.org/ (Open Access) -
Soft tissue and visceral sarcomas : ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆In: Annals of Oncology Vol. 32 (2021) Nr. 11,
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib : A clinical validation studyIn: The Lancet Oncology Vol. 22 (2021) Nr. 3, pp. 370 - 380
ISSN: 1470-2045; 1474-5488Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Sugar-modified B-cell receptors in DLBCLIn: Blood Vol. 138 (2021) Nr. 17, pp. 1512 - 1514
ISSN: 1528-0020; 0006-4971Online Full Text: dx.doi.org/ -
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19 : Current evidence and potential mechanismsIn: Molecular Psychiatry Vol. 26 (2021) Nr. 12, pp. 7098 - 7099
ISSN: 1476-5578; 1359-4184Online Full Text: dx.doi.org/ (Open Access) -
GPR15 facilitates recruitment of regulatory T cells to promote colorectal cancerIn: Cancer Research Vol. 81 (2021) Nr. 11, pp. 2970 - 2982
ISSN: 1538-7445; 0008-5472Online Full Text: dx.doi.org/; Online Full Text: dx.doi.org/ (Open Access) -
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypesIn: Nature Communications Vol. 12 (2021) Nr. 1, pp. 2048
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Mutations in the IFNγ-JAK-STAT pathway causing resistance to immune checkpoint inhibitors in melanoma increase sensitivity to oncolytic virus treatmentIn: Clinical Cancer Research Vol. 27 (2021) Nr. 12, pp. 3432 - 3442
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ -
Molecular biology of Hodgkin lymphomaIn: Leukemia Vol. 35 (2021) Nr. 4, pp. 968 - 981
ISSN: 1476-5551; 0887-6924Online Full Text: dx.doi.org/ (Open Access) -
Leadership challenges defusedIn: Science Vol. 371 (2021) Nr. 6533, pp. 1070
ISSN: 1095-9203; 0036-8075Online Full Text: dx.doi.org/ (Open Access) -
Resistance to avapritinib in pdgfra-driven gist is caused by secondary mutations in the pdgfra kinase domainIn: Cancer Discovery Vol. 11 (2021) Nr. 1, pp. 108 - 125
ISSN: 2159-8290; 2159-8274Online Full Text: dx.doi.org/ -
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113) : a multicentre, randomised, phase 2 trialIn: The Lancet Gastroenterology & Hepatology Vol. 6 (2021) Nr. 2, pp. 128 - 138
ISSN: 2468-1253Online Full Text: dx.doi.org/ -
Altered mitochondria functionality defines a metastatic cell state in lung cancer and creates an exploitable vulnerabilityIn: Cancer Research Vol. 81 (2021) Nr. 3, pp. 567 - 579
ISSN: 0008-5472; 1538-7445Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DMIn: Blood Vol. 137 (2021) Nr. 7, pp. 923 - 928
ISSN: 1528-0020; 0006-4971Online Full Text: dx.doi.org/ -
Functional Comparison of Interferon-α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon-α and Interferon-γ SignalingIn: Hepatology Vol. 73 (2021) Nr. 2, pp. 486 - 502
ISSN: 1527-3350; 0270-9139Online Full Text: dx.doi.org/ -
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasionIn: Nature Genetics Vol. 53 (2021) Nr. 3, pp. 332 - 341
ISSN: 1061-4036; 1546-1718Online Full Text: dx.doi.org/; Online Full Text: dx.doi.org/ (Open Access) -
Corrigendum to “Inhibiting fibroblast growth factor receptors in cancer – The next generation”In: Annals of Oncology Vol. 32 (2021) Nr. 1, pp. 126
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemiaIn: Leukemia Vol. 35 (2021) Nr. 2, pp. 585 - 594
ISSN: 1476-5551; 0887-6924Online Full Text: dx.doi.org/ -
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19In: Nature Communications Vol. 12 (2021) Nr. 1, pp. 1813
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
The West German heart and vascular center at university medicine EssenIn: European Heart Journal Vol. 42 (2021) Nr. 10, pp. 963 - 964
ISSN: 0195-668X; 1522-9645Online Full Text: dx.doi.org/ (Open Access) -
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapyIn: Nature Communications Vol. 12 (2021) Nr. 1, pp. 346
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache : A multicentre, double-blind, randomised controlled trialIn: The Lancet Neurology Vol. 20 (2021) Nr. 1, pp. 29 - 37
ISSN: 1474-4465; 1474-4422Online Full Text: dx.doi.org/ -
UMI or not UMI, that is the question for scRNA-seq zero-inflationIn: Nature Biotechnology Vol. 39 (2021) Nr. 2, pp. 158 - 159
ISSN: 1087-0156; 1546-1696; 0733-222XOnline Full Text: dx.doi.org/ -
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal FluidIn: Immunity Vol. 54 (2021) Nr. 1, pp. 164
ISSN: 1097-4180; 1074-7613Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA HeterogeneityIn: Clinical Cancer Research Vol. 26 (2020) Nr. 12, pp. 2946 - 2955
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Anemia increases long-term mortality in patients undergoing conventional coronary angiography – the ECAT registry
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal Vol. 41 (2020) Nr. Supplement_2, pp. 1508
ISSN: 0195-668X; 1522-9645Online Full Text: dx.doi.org/ (Open Access) -
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samplesIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 6232
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Co-option of Neutrophil Fates by Tissue EnvironmentsIn: Cell Vol. 183 (2020) Nr. 5, pp. 1282 - 1297.e18
ISSN: 1097-4172; 0092-8674Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to ImmunotherapyIn: Clinical Cancer Research Vol. 26 (2020) Nr. 21, pp. 5638 - 5645
ISSN: 1078-0432; 1557-3265Online Full Text: dx.doi.org/ (Open Access) -
Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK PathwayIn: Cancer Research Vol. 80 (2020) Nr. 21, pp. 4655 - 4667
ISSN: 0008-5472; 1538-7445; 0099-7013; 0099-7374Online Full Text: dx.doi.org/ (Open Access) -
Integrated molecular drivers coordinate biological and clinical states in melanomaIn: Nature Genetics Vol. 52 (2020) Nr. 12, pp. 1373 - 1383
ISSN: 1061-4036; 1546-1718Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma : safety run-in and biomarker cohorts of COMBI-iIn: Nature Medicine Vol. 26 (2020) Nr. 10, pp. 1557 - 1563
ISSN: 1546-170X; 1078-8956Online Full Text: dx.doi.org/ -
Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypesIn: Blood Vol. 136 (2020) Nr. 12, pp. 1419 - 1432
ISSN: 1528-0020Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanomaIn: Nature Vol. 580 (2020) Nr. 7801, pp. E1
ISSN: 1476-4687; 0028-0836Online Full Text: dx.doi.org/ (Open Access) -
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaIn: Nature Medicine Vol. 26 (2020) Nr. 7, pp. 1147
ISSN: 1546-170X; 1078-8956Online Full Text: dx.doi.org/ (Open Access) -
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III MelanomaIn: The New England Journal of Medicine Vol. 383 (2020) Nr. 12, pp. 1139 - 1148
ISSN: 1533-4406; 0028-4793Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients with Metastatic Soft Tissue Sarcoma Age 60 Years or Older : Results of a German Intergroup StudyIn: Journal of Clinical Oncology Vol. 38 (2020) Nr. 30, pp. 3555 - 3564
ISSN: 1527-7755; 0732-183XOnline Full Text: dx.doi.org/ -
Radiotheranostics : A roadmap for future developmentIn: The Lancet Oncology Vol. 21 (2020) Nr. 3, pp. e146 - e156
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Safety profile of ripretinib, including impact of alopecia, and Palmar-Plantar Erythrodysesthesia Syndrome (PPES) on patient-reported outcomes (PROs), in ≥ fourth-line advanced gastrointestinal stromal tumors (GIST) : Analyses from INVICTUSIn: Journal of Clinical Oncology Vol. 38 (2020) Nr. 15_Suppl., pp. 11539
ISSN: 0732-183X; 1527-7755Online Full Text: dx.doi.org/ -
The quest for efficient trial designs in precision oncologyIn: The Lancet Oncology Vol. 21 (2020) Nr. 12, pp. 1539 - 1541
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ -
Quality of life (QoL) and self-reported function with ripretinib in ≥4th-line therapy for patients with gastrointestinal stromal tumors (GIST) : Analyses from INVICTUSIn: Journal of Clinical Oncology Vol. 38 (2020) Nr. 15_Suppl., pp. 11535
ISSN: 0732-183X; 1527-7755Online Full Text: dx.doi.org/ -
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samplesIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 4748
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Sex differences in oncogenic mutational processesIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 4330
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Survival Outcomes Associated with 3 Years vs 1 Year of Adjuvant Imatinib for Patients with High-Risk Gastrointestinal Stromal Tumors : An Analysis of a Randomized Clinical Trial after 10-Year Follow-upIn: JAMA Oncology Vol. 6 (2020) Nr. 8, pp. 1241 - 1246
ISSN: 2374-2445; 2374-2437Online Full Text: dx.doi.org/ (Open Access) -
Prognosis of patients with stage III melanoma according to American joint committee on cancer version 8 : A reassessment on the basis of 3 independent stage III melanoma cohortsIn: Journal of Clinical Oncology Vol. 38 (2020) Nr. 22, pp. 2543 - 2551
ISSN: 1527-7755; 0732-183XOnline Full Text: dx.doi.org/ (Open Access) -
Rationale for Immune Checkpoint Inhibitors plus Targeted Therapy in Metastatic Melanoma : A ReviewIn: JAMA Oncology Vol. 6 (2020) Nr. 12, pp. 1957 - 1966
ISSN: 2374-2445; 2374-2437Online Full Text: dx.doi.org/ -
Cemiplimab in locally advanced cutaneous squamous cell carcinoma : results from an open-label, phase 2, single-arm trialIn: The Lancet Oncology Vol. 21 (2020) Nr. 2, pp. 294 - 305
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV⁶⁰⁰-mutant, stage III melanoma (COMBI-AD) : Exploratory biomarker analyses from a randomised, phase 3 trialIn: The Lancet Oncology Vol. 21 (2020) Nr. 3, pp. 358 - 372
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR) : A multicentre, open-label, phase 1 trialIn: The Lancet Oncology Vol. 21 (2020) Nr. 7, pp. 935 - 946
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ -
Cancer cells stock up in lymph vessels to surviveIn: Nature Vol. 585 (2020) Nr. 7823, pp. 36 - 37
ISSN: 1476-4687; 0028-0836Online Full Text: dx.doi.org/ (Open Access) -
Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced Melanoma : Pooled Analysis of 3 Clinical TrialsIn: JAMA Oncology Vol. 6 (2020) Nr. 8, pp. 1256 - 1264
ISSN: 2374-2445; 2374-2437Online Full Text: dx.doi.org/ (Open Access) -
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv⁶⁰⁰ mutation–positive melanoma receiving adjuvant vemurafenibIn: Annals of Oncology Vol. 31 (2020) Nr. 1, pp. 153 - 159
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapyIn: The Lancet Oncology Vol. 21 (2020) Nr. 9, pp. e431 - e443
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Durable and controlled depletion of neutrophils in miceIn: Nature Communications Vol. 11 (2020) pp. 2762
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Biochemical evidence for Ku-independent backup pathways of NHEJIn: Nucleic Acids Research Vol. 48 (2020) Nr. 9, pp. 5200
ISSN: 1362-4962; 0301-5610; 0305-1048Online Full Text: dx.doi.org/ (Open Access) -
Crizotinib in ROS1 and MET deregulated NSCLC-letterIn: Clinical Cancer Research Vol. 26 (2020) Nr. 7, pp. 1774
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ -
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanomaIn: Annals of Oncology Vol. 31 (2020) Nr. 1, pp. 144 - 152
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor TransplantationIn: Journal of Clinical Oncology Vol. 38 (2020) Nr. 24, pp. 2712 - 2718
ISSN: 1527-7755; 0732-183XOnline Full Text: dx.doi.org/ Online Full Text (Open Access) -
A clinical perspective on the 2019 ESC/EAS guidelines for the management of dyslipidaemias: PCSK-9 inhibitors for all?In: European Heart Journal Vol. 41 (2020) Nr. 24, pp. 2331
ISSN: 1522-9645Online Full Text: dx.doi.org/ -
A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus controlIn: Journal of Hepatology Vol. 72 (2020) Nr. 5, pp. 960 - 975
ISSN: 1600-0641; 0168-8278Online Full Text: dx.doi.org/ (Open Access) -
Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe diseaseIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 1338
ISSN: 2041-1723Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Dead Cells Induce Innate Anergy via Mertk after Acute Viral InfectionIn: Cell Reports Vol. 30 (2020) Nr. 11, pp. 3671 - 3681.e5
ISSN: 2211-1247Online Full Text: dx.doi.org/ (Open Access) -
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumoursIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 1335
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Cardiac fibroblast activation detected by positron emission tomography/computed tomography as a possible sign of cardiotoxicityIn: European Heart Journal Vol. 41 (2020) Nr. 9, pp. 1060
ISSN: 1522-9645; 0195-668XOnline Full Text: dx.doi.org/ -
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors failsIn: Blood Vol. 135 (2020) Nr. 16, pp. 1386 - 1395
ISSN: 1528-0020; 0006-4971Online Full Text: dx.doi.org/ (Open Access) -
Association between Immune-Related Adverse Events and Recurrence-Free Survival among Patients with Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo : A Secondary Analysis of a Randomized Clinical TrialIn: JAMA Oncology Vol. 6 (2020) Nr. 4, pp. 519 - 527
ISSN: 2374-2445; 2374-2437Online Full Text: dx.doi.org/ (Open Access) -
Nusinersen in adults with 5q spinal muscular atrophy : A non-interventional, multicentre, observational cohort studyIn: The Lancet Neurology Vol. 19 (2020) Nr. 4, pp. 317 - 325
ISSN: 1474-4465; 1474-4422Online Full Text: dx.doi.org/ -
Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injuryIn: Gut Vol. 69 (2020) Nr. 1, pp. 133 - 145
ISSN: 1468-3288; 0017-5749Online Full Text: dx.doi.org/ (Open Access) -
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibilityIn: Nature Genetics Vol. 52 (2020) Nr. 5, pp. 494 - 504
ISSN: 1061-4036; 1546-1718Online Full Text: dx.doi.org/ -
Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activityIn: Cancer Research Vol. 80 (2020) Nr. 4, pp. 798 - 810
ISSN: 1538-7445; 0008-5472Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Immunotherapeutic blockade of CD47 inhibitory signaling enhances innate and adaptive immune responses to viral infectionIn: Cell Reports Vol. 31 (2020) Nr. 2, pp. 107494
ISSN: 2211-1247Online Full Text: dx.doi.org/ (Open Access) -
Involvement of Hus1 in the chain elongation step of DNA replication after exposure to camptothecin or ionizing radiationIn: Nucleic Acids Research Vol. 48 (2020) Nr. 6, pp. 3396
ISSN: 1362-4962; 0301-5610; 0305-1048Online Full Text: dx.doi.org/ (Open Access) -
A combined experimental and modelling approach for the Weimberg pathway optimisationIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 1098
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Heterobifunctional Rotaxanes for Asymmetric CatalysisIn: Angewandte Chemie International Edition Vol. 59 (2020) Nr. 13, pp. 5102 - 5107
ISSN: 1521-3773; 1433-7851; 0570-0833Online Full Text: dx.doi.org/ (Open Access) -
Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signalingIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 3547
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS) : a double-blind, randomised, placebo-controlled, phase 3 trialIn: The Lancet Oncology Vol. 21 (2020) Nr. 7, pp. 923 - 934
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell CarcinomaIn: Clinical Cancer Research Vol. 26 (2020) Nr. 9, pp. 2257 - 2267
ISSN: 1078-0432; 1557-3265Online Full Text: dx.doi.org/ (Open Access) -
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 2465
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer : Clinical and biomarker results from a phase I trialIn: Annals of Oncology (2020)
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Refining endpoints for stroke recovery trialsIn: The Lancet Neurology Vol. 19 (2020) Nr. 5, pp. 381 - 382
ISSN: 1474-4465; 1474-4422Online Full Text: dx.doi.org/ (Open Access) -
Pan-cancer analysis of whole genomesIn: Nature Vol. 578 (2020) Nr. 7793, pp. 82 - 93
ISSN: 0028-0836; 1476-4687Online Full Text: dx.doi.org/ (Open Access) -
Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healingIn: Gut Vol. 69 (2020) pp. 252 - 263
ISSN: 1468-3288; 0017-5749Online Full Text: dx.doi.org/ -
Thyroid Hormone TransportersIn: Endocrine Reviews Vol. 41 (2020) Nr. 2, pp. 146 - 201
ISSN: 1945-7189; 0163-769XOnline Full Text: dx.doi.org/ (Open Access) -
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsIn: Acta Neuropathologica Vol. 139 (2020) Nr. 2, pp. 243 - 257
ISSN: 1432-0533; 0001-6322Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Metabolic heterogeneity confers differences in melanoma metastatic potentialIn: Nature Vol. 577 (2020) Nr. 7788, pp. 115 - 120
ISSN: 1476-4687; 0028-0836Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosisIn: Gut Vol. 69 (2020) Nr. 7, pp. 1269 - 1282
ISSN: 0017-5749Online Full Text: dx.doi.org/ -
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke : A multicentre, double-blind, randomised, placebo-controlled trialIn: The Lancet Neurology Vol. 19 (2020) Nr. 3, pp. 226 - 233
ISSN: 1474-4465; 1474-4422Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Tertiary lymphoid structures improve immunotherapy and survival in melanomaIn: Nature Vol. 577 (2020) Nr. 7791, pp. 561 - 565
ISSN: 0028-0836; 1476-4687Online Full Text: dx.doi.org/ -
Strong suppression of gene conversion with increasing DNA double-strand break load delimited by 53BP1 and RAD52In: Nucleic Acids Research Vol. 48 (2020) Nr. 4, pp. 1905 - 1924
ISSN: 1362-4962; 0305-1048Online Full Text: dx.doi.org/ (Open Access) -
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerabilityIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 4684
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide TherapyIn: Gastroenterology Vol. 158 (2020) Nr. 8, pp. 2180 - 2194
ISSN: 1528-0012; 0016-5085Online Full Text: dx.doi.org/ (Open Access) -
TPC1 deficiency or blockade augments systemic anaphylaxis and mast cell activityIn: Proceedings of the National Academy of Sciences of the United States of America Vol. 117 (2020) Nr. 30, pp. 18068 - 18078
ISSN: 1091-6490; 0027-8424Online Full Text: dx.doi.org/ (Open Access) -
3D extracellular matrix microenvironment in bioengineered tissue models of primary pediatric and adult brain tumorsIn: Nature Communications Vol. 10 (2019) pp. 4529
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Activity and tolerability of BLU-667, a highly potent and selective RET inhibitor, in patients with advanced RET-altered thyroid cancersIn: Journal of Clinical Oncology Vol. 37 (2019) Nr. 15_Suppl, pp. 6018
ISSN: 0732-183X; 1527-7755Online Full Text: dx.doi.org/ -
Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphomaIn: Blood Vol. 134 (2019) Nr. 13, pp. 1072 - 1083
ISSN: 1528-0020; 0006-4971Online Full Text: dx.doi.org/ (Open Access) -
Axon-like protrusions promote small cell lung cancer migration and metastasisIn: eLife Vol. 8 (2019) pp. e50616
ISSN: 2050-084XOnline Full Text: dx.doi.org/ (Open Access) -
Circulating tumor DNA (ctDNA) kinetics to predict survival in patients (pts) with unresectable or metastatic melanoma treated with dabrafenib (D) or D + trametinib (T)In: Journal of Clinical Oncology Vol. 37 (2019) Nr. 15_suppl, pp. 9510
ISSN: 0732-183X; 1527-7755Online Full Text: dx.doi.org/ -
Distinct immunogenomic properties of melanomas with stable disease as best response to immune checkpoint blockade (ICB)In: Journal of Clinical Oncology Vol. 37 (2019) Nr. 15_Suppl, pp. 2515 - 2515
ISSN: 0732-183X; 1527-7755Online Full Text: dx.doi.org/ -
Human gastric cancer modelling using organoidsIn: Gut Vol. 68 (2019) Nr. 2, pp. 207 - 217
ISSN: 1468-3288; 0017-5749Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaIn: Nature Medicine Vol. 25 (2019) Nr. 12, pp. 1916 - 1927
ISSN: 1546-170X; 1078-8956Online Full Text: dx.doi.org/ (Open Access) -
Assessment of ⁶⁸ Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialIn: JAMA Oncology Vol. 5 (2019) Nr. 6, pp. 856 - 863
ISSN: 2374-2445; 2374-2437Online Full Text: dx.doi.org/ (Open Access) -
Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal CancerIn: Immunity Vol. 50 (2019) Nr. 1, pp. 166 - 180.e7
ISSN: 1097-4180; 1074-7613Online Full Text: dx.doi.org/ (Open Access) -
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and MetastasisIn: Cancer Cell Vol. 36 (2019) Nr. 3, pp. 319 - 336.e7
ISSN: 1535-6108; 1878-3686Online Full Text: dx.doi.org/ (Open Access) -
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms Across Eight Psychiatric DisordersIn: Cell Vol. 179 (2019) Nr. 7, pp. 1469 - 1482.e11.
ISSN: 0092-8674; 1097-4172Online Full Text: dx.doi.org/ (Open Access) -
Melanoma extracellular vesicles generate immunosuppressive myeloid cells by upregulating PD-L1 via TLR4 signalingIn: Cancer Research Vol. 79 (2019) Nr. 18, pp. 4715 - 4728
ISSN: 0099-7013; 0008-5472Online Full Text: dx.doi.org/ (Open Access) -
Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 2312
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Alpelisib Plus Fulvestrant in PIK3CA -Altered and PIK3CA -Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer : A Phase 1b Clinical TrialIn: JAMA Oncology Vol. 5 (2019) Nr. 2, pp. e184475
ISSN: 2374-2445; 2374-2437Online Full Text: dx.doi.org/ (Open Access) -
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines CommitteesIn: Annals of Oncology Vol. 30 (2019) Nr. 11, pp. 1697 - 1727
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Covalent-Allosteric Inhibitors to Achieve Akt Isoform-SelectivityIn: Angewandte Chemie International Edition Vol. 58 (2019) Nr. 52, pp. 18823 - 18829
ISSN: 1433-7851; 1521-3773Online Full Text: dx.doi.org/ (Open Access) -
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus : the MONO studyIn: Annals of Oncology Vol. 30 (2019) Nr. 9, pp. 1487 - 1495
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaIn: The New England Journal of Medicine Vol. 381 (2019) Nr. 16, pp. 1535 - 1546
ISSN: 1533-4406; 0028-4793Online Full Text: dx.doi.org/ (Open Access) -
ctDNA as a noninvasive monitoring tool in metastatic melanomaIn: Journal of Clinical Oncology Vol. 37 (2019) Nr. Suppl. 15, pp. 9548
ISSN: 0732-183X; 1527-7755Online Full Text: dx.doi.org/ -
Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancerIn: Clinical Cancer Research Vol. 25 (2019) Nr. 24, pp. 7448 - 7454
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ (Open Access) -
Current gaps in sepsis immunology: new opportunities for translational researchIn: The Lancet Infectious Diseases Vol. 19 (2019) Nr. 12, pp. e422 - e436
ISSN: 1474-4457; 1473-3099Online Full Text: dx.doi.org/ (Open Access) -
Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunityIn: FEMS Microbiology Reviews Vol. 43 (2019) Nr. 5, pp. 435 - 456
ISSN: 1574-6976; 0168-6445Online Full Text: dx.doi.org/ -
Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infectionIn: Journal of Hepatology Vol. 70 (2019) Nr. 1 Suppl., pp. e81
ISSN: 0168-8278Online Full Text: dx.doi.org/ -
Publisher Correction : Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathwaysIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 299
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosaIn: Nature Genetics Vol. 51 (2019) Nr. 8, pp. 1207 - 1214
ISSN: 1061-4036; 1546-1718Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationIn: Nature Medicine Vol. 25 (2019) Nr. 4, pp. 603 - 611
ISSN: 1546-170X; 1078-8956Online Full Text: dx.doi.org/ -
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphomaIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 1459
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancerIn: Annals of Oncology Vol. 30 (2019) Nr. 4, pp. 655 - 657
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Defective homologous recombination DNA repair as therapeutic target in advanced chordomaIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 1635
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
HDAC8 regulates a stress response pathway in melanoma to mediate escape from BRAF inhibitor therapyIn: Cancer Research Vol. 79 (2019) Nr. 11, pp. 2947 - 2961
ISSN: 0008-5472; 0099-7013; 0099-7374; 1538-7445Online Full Text: dx.doi.org/ (Open Access) -
Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell deathIn: Nature Vol. 569 (2019) Nr. 7755, pp. 236 - 240
ISSN: 0028-0836; 1476-4687Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Five-year outcomes with dabrafenib plus trametinib in metastatic melanomaIn: The New England Journal of Medicine Vol. 381 (2019) Nr. 7, pp. 626 - 636
ISSN: 1533-4406; 0028-4793Online Full Text: dx.doi.org/ (Open Access) -
Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope ProteinsIn: Cell Reports Vol. 27 (2019) Nr. 7, pp. 2092 - 2104.e10
ISSN: 2211-1247Online Full Text: dx.doi.org/ (Open Access) -
MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearanceIn: Journal of Hepatology Vol. 71 (2019) Nr. 4, pp. 685 - 698
ISSN: 1600-0641; 0168-8278Online Full Text: dx.doi.org/ -
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt LymphomaIn: Cancer Research Vol. 79 (2019) Nr. 12, pp. 3125 - 3138
ISSN: 1538-7445; 0008-5472Online Full Text: dx.doi.org/ (Open Access) -
Microglial cell loss after ischemic stroke favors brain neutrophil accumulationIn: Acta Neuropathologica Vol. 137 (2019) Nr. 2, pp. 321 - 341
ISSN: 1432-0533; 0001-6322Online Full Text: dx.doi.org/ (Open Access) -
Quality of life (QoL) and symptom burden in patients (pts) with advanced melanoma during the treatment-free interval (TFI) after discontinuation of nivolumab (NIVO) or NIVO plus ipilimumab (IPI)In: Journal of Clinical Oncology Vol. 37 (2019) Nr. 15_Suppl, pp. 9568
ISSN: 0732-183X; 1527-7755Online Full Text: dx.doi.org/ -
Salvage therapy after failure from anti-PD-1 single agent treatment : A Study by the German ADOReg melanoma registryIn: Journal of Clinical Oncology Vol. 37 (2019) Nr. 15_Suppl, pp. 9505
ISSN: 0732-183X; 1527-7755Online Full Text: dx.doi.org/ -
Reply [Letter to the Editor: Characterization of CD169+ Macrophages in Liver Regeneration: Tissue Distribution and Fate?]In: Hepatology Vol. 70 (2019) Nr. 3, pp. 1074 - 1075
ISSN: 0270-9139; 1527-3350Online Full Text: dx.doi.org/ -
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression : a phase 1 dose-escalation and dose-expansion studyIn: The Lancet Oncology Vol. 20 (2019) Nr. 10, pp. 1454 - 1466
ISSN: 1470-2045; 1474-5488Online Full Text: dx.doi.org/ -
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in MelanomaIn: Cell Reports Vol. 27 (2019) Nr. 12, pp. 3573 - 3586.e7
ISSN: 2211-1247Online Full Text: dx.doi.org/ (Open Access) -
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal CancerIn: Cancer Research Vol. 79 (2019) Nr. 9, pp. 2367 - 2378
ISSN: 0008-5472; 1538-7445; 0099-7013; 0099-7374Online Full Text: dx.doi.org/ (Open Access) -
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL) : a multicentre, open-label, randomised, controlled phase II trialIn: Annals of Oncology Vol. 30 (2019) Nr. 2, pp. 317 - 324
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD) : a randomised, placebo-controlled, phase 3 trialIn: The Lancet Oncology Vol. 20 (2019) Nr. 5, pp. 701 - 710
ISSN: 1474-5488Online Full Text: dx.doi.org/ -
Treatment in metastatic melanoma : Time to re-thinkIn: Annals of Oncology Vol. 30 (2019) Nr. 4, pp. 501 - 503
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Publisher Correction: Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 2768
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathwaysIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 299
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Survival Outcomes in Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma Treated with Nivolumab Therapy : Three-Year Follow-up of a Randomized Phase 3 TrialIn: JAMA Oncology Vol. 5 (2019) Nr. 2, pp. 187 - 194
ISSN: 2374-2445; 2374-2437Online Full Text: dx.doi.org/ (Open Access) -
Zolbetuximab combined with EOX as first-line therapy in advanced CLDN18.2+ gastric (G) and gastroesophageal junction (GEJ) adenocarcinoma : Updated results from the FAST trial.In: Journal of Clinical Oncology Vol. 37 (2019) Nr. 4_Suppl, pp. 16
ISSN: 0732-183X; 1527-7755Online Full Text: dx.doi.org/ -
The intramembrane protease SPPL2c promotes male germ cell development by cleaving phospholambanIn: EMBO Reports Vol. 20 (2019) Nr. 3, pp. e46449
ISSN: 1469-3178; 1469-221XOnline Full Text: dx.doi.org/ Online Full Text (Open Access) -
Weightlifting unmasks high-risk coronary anomalyIn: European Heart Journal Vol. 40 (2019) Nr. 1, pp. 72
ISSN: 0195-668X; 1522-9645Online Full Text: dx.doi.org/ (Open Access) -
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8⁺ T Cells and Evolve at the Population LevelIn: Gastroenterology Vol. 156 (2019) Nr. 6, pp. 1820 - 1833
ISSN: 0016-5085; 1528-0012Online Full Text: dx.doi.org/ (Open Access) -
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsIn: Cell Vol. 176 (2019) Nr. 3, pp. 505 - 519.e22
ISSN: 0092-8674; 1097-4172Online Full Text: dx.doi.org/ (Open Access) -
Understanding HDV and HBsAg kinetics during nucleic acid polymer REP 2139 mono-therapy in HBeAg-negative chronic HBV/HDV co-infected patients via mathematical modelingIn: Journal of Hepatology Vol. 70 (2019) Nr. 1 Suppl., pp. e463
ISSN: 0168-8278Online Full Text: dx.doi.org/ -
Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib plus trametinib (D plus T) in patients (pts) with resected BRAF V600-mutant stage III melanomaIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8,
ISSN: 1569-8041; 0923-7534 -
Adverse events (AEs) over time in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (Pbo) in the COMBI-AD trialIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii446
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphomaIn: Leukemia Vol. 32 (2018) Nr. 1, pp. 92 - 101
ISSN: 0887-6924; 1476-5551Online Full Text: dx.doi.org/ -
VOYAGER : An open-label, randomised, phase III study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresectable gastrointestinal stromal tumour (GIST)In: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii595
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Author Correction : The landscape of genomic alterations across childhood cancersIn: Nature Vol. 559 (2018) Nr. 7714, pp. E10
ISSN: 0028-0836; 1476-4687Online Full Text: dx.doi.org/ (Open Access) -
Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib + trametinib (D + T) in patients (pts) with resected BRAF V600-mutant stage III melanomaIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii734 - viii735
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
A distinct oncogenerative multinucleated cancer cell serves as a source of stemness and tumor heterogeneityIn: Cancer Research Vol. 78 (2018) Nr. 9, pp. 2318 - 2331
ISSN: 0008-5472; 1538-7445Online Full Text: dx.doi.org/ (Open Access) -
A mechanistic classification of clinical phenotypes in neuroblastomaIn: Science Vol. 362 (2018) Nr. 6419, pp. 1165 - 1170
ISSN: 1095-9203; 0036-8075Online Full Text: dx.doi.org/ (Open Access) -
Adjuvant melanoma therapy with new drugs : should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?In: The Lancet Oncology Vol. 19 (2018) Nr. 12, pp. e720 - e725
ISSN: 1470-2045; 1474-5488Online Full Text: dx.doi.org/ -
Age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-Cell populationsIn: Clinical Cancer Research Vol. 24 (2018) Nr. 21, pp. 5347 - 5356
ISSN: 1078-0432; 1557-3265Online Full Text: dx.doi.org/ (Open Access) -
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeIn: Cell Vol. 175 (2018) Nr. 4, pp. 984 - 997.e24
ISSN: 1097-4172; 0092-8674Online Full Text: dx.doi.org/ (Open Access) -
Bone sarcomas : ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 4, pp. iv79 - iv95
ISSN: 0923-7534Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide–MHC complexesIn: Nature Biotechnology Vol. 36 (2018) Nr. 12, pp. 1191 - 1196
ISSN: 1546-1696; 1087-0156; 0733-222XOnline Full Text: dx.doi.org/ Online Full Text (Open Access) -
Antidepressants act by inducing autophagy controlled by sphingomyelin–ceramideIn: Molecular Psychiatry Vol. 23 (2018) pp. 2324 - 2346
ISSN: 1476-5578; 1359-4184Online Full Text: dx.doi.org/ (Open Access) -
Antidepressants regulate autophagy by targeting acid sphingomyelinaseIn: Molecular Psychiatry Vol. 23 (2018) Nr. 12, pp. 2251
ISSN: 1359-4184; 1476-5578Online Full Text: dx.doi.org/ (Open Access) -
B Cell-Mediated Maintenance of Cluster of Differentiation 169–Positive Cells Is Critical for Liver RegenerationIn: Hepatology Vol. 68 (2018) Nr. 6, pp. 2348 - 2361
ISSN: 1527-3350; 0270-9139Online Full Text: dx.doi.org/ (Open Access) -
Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individualsIn: Blood Vol. 131 (2018) Nr. 5, pp. 546 - 557
ISSN: 1528-0020; 0006-4971Online Full Text: dx.doi.org/ (Open Access) -
CEACAM1 promotes CD8⁺ T cell responses and improves control of a chronic viral infectionIn: Nature Communications Vol. 9 (2018)
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Establishment of High Rates of Functional Control and Reversal of Fibrosis Following Treatment of Hbeag Negative Chronic HBV Infection with REP 2139-Mg / REP 2165-Mg, Tenofovir Disoproxil Fumarate and Pegylated Interferon Alpha-2aIn: Hepatology Vol. 68 (2018) Nr. S1, pp. 234A - 235A
ISSN: 0270-9139Online Full Text: dx.doi.org/ (Open Access) -
Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand BreaksIn: Cell Reports Vol. 25 (2018) Nr. 4, pp. 1040 - 1050.e5
ISSN: 2211-1247Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
IG-MYC⁺ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasIn: Blood Vol. 132 (2018) Nr. 21, pp. 2280 - 2285
ISSN: 1528-0020Online Full Text: dx.doi.org/ (Open Access) -
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy : a retrospective, multicohort analysisIn: The Lancet Oncology Vol. 19 (2018) Nr. 3, pp. 310 - 322
ISSN: 1470-2045Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3 : European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'In: Annals of Oncology Vol. 29 (2018) Nr. 3, pp. 758 - 765
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Distinct Gene Expression Patterns Drive Proliferation of Dominant-Negative RUNX1 Immortalized HSPCs
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Vol. 132 (2018) Nr. Supplement 1, pp. 1795 - 1795
ISSN: 1528-0020; 0006-4971Online Full Text: dx.doi.org/ (Open Access) -
Adjuvant pembrolizumab versus placebo in resected stage III melanomaIn: The New England Journal of Medicine Vol. 378 (2018) Nr. 19, pp. 1789 - 1801
ISSN: 1533-4406; 0028-4793Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Prognostic value of baseline biliary stents on outcomes in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the NAPOLI-1 trialIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 5, pp. v42
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 BlockadeIn: Cell Vol. 173 (2018) Nr. 3, pp. 624 - 633.e8
ISSN: 1097-4172; 0092-8674Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Correlation of ctDNA and response in patients (pts) with PDGFRα D842 GIST treated with avapritinibIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii584
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Corrigendum: Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cellsIn: EMBO Reports Vol. 19 (2018) Nr. 12, pp. e47190
ISSN: 1469-3178; 1469-221XOnline Full Text: dx.doi.org/ Online Full Text (Open Access) -
Critical influences on the pathogenesis of follicular lymphomaIn: Blood Vol. 131 (2018) Nr. 21, pp. 2297 - 2306
ISSN: 1528-0020; 0006-4971Online Full Text: dx.doi.org/ (Open Access) -
Differential impact of pure glyphosate and glyphosate-based herbicide in a model of peripheral nervous system myelinationIn: Acta Neuropathologica Vol. 136 (2018) Nr. 6, pp. 979 - 982
ISSN: 1432-0533; 0001-6322Online Full Text: dx.doi.org/ -
Overall survival at 4 years of follow-up in a phase III trial of nivolumab plus ipilimumab combination therapy in advanced melanoma (CheckMate 067)In: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii735
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS) : a multicentre, open-label, randomised phase 3 trialIn: The Lancet Oncology Vol. 19 (2018) Nr. 5, pp. 603 - 615
ISSN: 1470-2045; 1474-5488Online Full Text: dx.doi.org/; Online Full Text: dx.doi.org/ (Open Access) -
Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCCIn: Hepatology Vol. 68 (2018) Nr. Suppl. 1, pp. 852A - 853A
ISSN: 0270-9139; 1527-3350 -
Circulating cell-free miR-375 as surrogate marker of tumor burden in Merkel cell carcinomaIn: Clinical Cancer Research Vol. 24 (2018) Nr. 23, pp. 5873 - 5882
ISSN: 1078-0432; 1557-3265Online Full Text: dx.doi.org/ (Open Access) -
Consensus on molecular imaging and theranostics in prostate cancerIn: The Lancet Oncology Vol. 19 (2018) Nr. 12, pp. e696 - e708
ISSN: 1470-2045; 1474-5488Online Full Text: dx.doi.org/ -
DNA methylation-based classification of central nervous system tumoursIn: Nature Vol. 555 (2018) Nr. 7697, pp. 469 - 474
ISSN: 0028-0836; 1476-4687Online Full Text: dx.doi.org/ (Open Access) -
Decreased appetite (DA) at baseline impacts prognosis in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC)In: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 5, pp. v42 - v43
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosisIn: Circulation Vol. 138 (2018) Nr. 16, pp. 1720 - 1735
ISSN: 0009-7322; 1524-4539Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapyIn: Clinical Cancer Research Vol. 24 (2018) Nr. 6, pp. 1364 - 1374
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ (Open Access) -
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 4, pp. iv68 - iv78
ISSN: 0923-7534; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Health-related quality of life (HR-QoL) in elderly soft tissue sarcoma (STS) patients from the randomized phase II EPAZ study comparing pazopanib (PAZ) and doxorubicin (DOX) in first lineIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii577
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trialIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii445
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Soft tissue and visceral sarcomas : ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 4, pp. iv51 - iv67
ISSN: 1569-8041; 0923-7534Online Full Text: dx.doi.org/ (Open Access) -
Helicobacter pylori adhesin HopQ disrupts trans dimerization in human CEACAMsIn: The EMBO Journal Vol. 37 (2018) Nr. 13,
ISSN: 1460-2075; 0261-4189Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Impact of dose reduction or dose delay on the efficacy of liposomal irinotecan (nal-IRI)+5-fluorouracil/leucovorin (5-FU/LV) : Survival analysis from NAPOLI-1In: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii250 - viii251
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathwaysIn: Nature Communications Vol. 9 (2018) Nr. 1, pp. 4774
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Sebaceous tumours: more than skin deepIn: Gut Vol. 67 (2018) Nr. 11, pp. 2045 - 2053
ISSN: 0017-5749; 1468-3288Online Full Text: dx.doi.org/ -
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS) : a multicentre, open-label, randomised, phase 3 trialIn: The Lancet Oncology Vol. 19 (2018) Nr. 10, pp. 1315 - 1327
ISSN: 1470-2045; 1474-5488Online Full Text: dx.doi.org/ -
Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotypeIn: Hepatology Vol. 67 (2018) Nr. 4, pp. 1237 - 1252
ISSN: 1527-3350; 0270-9139Online Full Text: dx.doi.org/ (Open Access) -
Integrated genomic classification of melanocytic tumors of the central nervous system using mutation analysis, copy number alterations, and DNA methylation profilingIn: Clinical Cancer Research Vol. 24 (2018) Nr. 18, pp. 4494 - 4504
ISSN: 1078-0432; 1557-3265Online Full Text: dx.doi.org/ (Open Access) -
NAPOLI-1 phase III trial outcomes by prior surgery, and disease stage, in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)In: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii249 - viii250
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Notch-induced myeloid reprogramming in spontaneous pancreatic ductal adenocarcinoma by dual genetic targetingIn: Cancer Research Vol. 78 (2018) Nr. 17, pp. 4997 - 5010
ISSN: 0008-5472; 1538-7445Online Full Text: dx.doi.org/ (Open Access) -
Correction: Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosaIn: Molecular Psychiatry Vol. 23 (2018) Nr. 9, pp. 1
ISSN: 1476-5578; 1359-4184Online Full Text: dx.doi.org/ (Open Access) -
Integrative genomic and transcriptomic analysis of leiomyosarcomaIn: Nature Communications Vol. 9 (2018) Nr. 1, pp. 144
ISSN: 2041-1723Online Full Text: dx.doi.org/ (Open Access) -
Sphingolipids as targets for inhalation treatment of cystic fibrosisIn: Advanced Drug Delivery Reviews Vol. 133 (2018) pp. 66 - 75
ISSN: 1872-8294; 0169-409XOnline Full Text: dx.doi.org/ -
The effect of best response to prior anticancer therapy on efficacy outcomes in the NAPOLI-1 trial of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapyIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 5, pp. v42
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell SubsetsIn: Clinical Cancer Research Vol. 24 (2018) Nr. 19, pp. 4834 - 4844
ISSN: 1078-0432; 1557-3265Online Full Text: dx.doi.org/ (Open Access) -
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable diseaseIn: The Lancet Oncology Vol. 19 (2018) Nr. 3, pp. e151 - e160
ISSN: 1470-2045; 1474-5488Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-PrimingIn: Cell Reports Vol. 22 (2018) Nr. 6, pp. 1484 - 1495
ISSN: 2211-1247Online Full Text: dx.doi.org/ (Open Access) -
PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinomaIn: The New England Journal of Medicine Vol. 379 (2018) Nr. 4, pp. 341 - 351
ISSN: 1533-4406; 0028-4793Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Role of elevated PHIP copy number as a prognostic and progression marker for cutaneous melanomaIn: Clinical Cancer Research Vol. 24 (2018) Nr. 17, pp. 4119 - 4125
ISSN: 1557-3265; 1078-0432Online Full Text: dx.doi.org/ (Open Access) -
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsIn: Nature Genetics Vol. 50 (2018) Nr. 9, pp. 1271 - 1281
ISSN: 1061-4036; 1546-1718Online Full Text: dx.doi.org/ Online Full Text (Open Access) -
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067) : 4-year outcomes of a multicentre, randomised, phase 3 trialIn: The Lancet Oncology Vol. 19 (2018) Nr. 11, pp. 1480 - 1492
ISSN: 1474-5488; 1470-2045Online Full Text: dx.doi.org/ -
The landscape of genomic alterations across childhood cancersIn: Nature Vol. 555 (2018) Nr. 7696, pp. 321 - 327
ISSN: 0028-0836; 1476-4687Online Full Text: dx.doi.org/ (Open Access) -
Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosaIn: Molecular Psychiatry Vol. 23 (2018) Nr. 5, pp. 1169 - 1180
ISSN: 1476-5578; 1359-4184Online Full Text: dx.doi.org/ (Open Access) -
Translational Insights into Gastrointestinal Stromal Tumor and Current Clinical AdvancesIn: Annals of Oncology Vol. 29 (2018) Nr. 10, pp. 2037 - 2045
ISSN: 0923-7534; 1569-8041Online Full Text: dx.doi.org/ (Open Access) -
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging GroupIn: The Lancet Oncology Vol. 19 (2018) Nr. 10, pp. e534 - e545
ISSN: 1470-2045; 1474-5488Online Full Text: dx.doi.org/ Online Full Text (Open Access)